The use of a second core needle biopsy to predict response to neoadjuvant chemotherapy in breast cancer patients, especially in the HER2-positive population-Reference-Cited by-同舟云学术

The use of a second core needle biopsy to predict response to neoadjuvant chemotherapy in breast cancer patients, especially in the HER2-positive population

Published:2020-12 Issue:6 Volume:168 Page:1115-1121
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Zhang Ying,Shen Juping,Wu Siyu,Zhou Ying,Shao Zhimin,Liu Guangyu

Publisher

Elsevier BV

Subject

Surgery

Reference21 articles.

1. The role of preoperative systemic treatment in patients with breast cancer;Debska-Szmich;Contemp Oncol (Pozn),2016

2. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

3. Correlation of various pathologic complete response (pCR) definitions with long-term outcome and the prognostic value of pCR in various breast cancer subtypes: Results from the German neoadjuvant meta-analysis;Von Minckwitz;J Clin Oncol,2011

4. NAB-Paclitaxel improves disease-free survival in early breast cancer: GBG 69-GeparSepto;Untch;J Clin Oncol,2019

5. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response;de Azambuja;Lancet Oncol,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeated core needle biopsy and targeted fine-needle aspiration to optimize axillary surgery after neoadjuvant chemotherapy in node-positive breast cancer: prospective clinical study;British Journal of Surgery;2023-05-30

2. Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study;International Journal of Surgery;2023-05-04